NOX:
Market Cap:
Price Delay ~20min
Entitlement Offer Prospectus
May/June 2020

Financial Reports


 
    Noxopharm March 2020 Quarterly Report & Appendix 4C  
 
    Half Year Accounts and Chairman Letter  
 
    Appendix 4C - Quarterly Report for The Quarter Ending December 31, 2019  
 
    Appendix 4C - Quarterly Report for The Quarter Ending September 30, 2019  
 
    FY 19 Appendix 4E and Audited Financial Statements  
 
    Appendix 4C - Quarterly Report for the quarter ending June 30, 2019  
 
    Appendix 4C - Quarterly Report for The Quarter Ending March 31 2019  
 
    Appendix 4D and Half Year Accounts  
 
    Appendix 4C - quarterly report for the quarter ended December 31, 2018  
 
    Appendix 4C - Quarterly report for the quarter ended September 30, 2018  
 
    Appendix 4E and Audited Financial Statements  
 
    Appendix 4C- Quarterly report for the quarter ended June 30, 2018  
 
    Appendix 4C- Quarterly report for the quarter ended March 31, 2018  
 
    Appendix 4D and Half Year Accounts  
 
    Appendix 4C - Quarterly report for the quarter ended December 31, 2017  
 
    Appendix 4C – Quarterly report for the quarter ended September 30, 2017  
 
    Appendix 4E and Audited Financial Statements  
 
    Appendix 4C – Quarterly report for the quarter ended June 30, 2017  
 
    Appendix 4C – Quarterly report for the quarter ended 31 March 2017  
 
    Appendix 3B  
 
    Appendix 4D and Half Year Accounts  
 
    Appendix 4C – Quarterly report for the quarter ended 31 December 2016  
 
    Appendix 3B  
 
    Market Capitalisation - further update  
 
    Appendix 3B  
 
    Results of Meeting  
 
    Appendix 4C – Quarterly report for the quarter ended 30 September 2016  
 
    Notice of 2016 AGM and 2016 Annual Report  
 
    Annual Report 2016  
 
    Financial Report